您现在的位置:首页 > 资料文献 > 靶向部位 > 肝脏

JCI: The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging

作者:市场部   发布于:2020/5/16 16:39:33  点击量:
Title:

The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging

Journal:JCIYear:2013
Abstract

Anti-CD20 Ab therapy has proven successful for treating B cell malignancies and a number of autoimmune diseases. However, how anti-CD20 Abs operate in vivo to mediate B cell depletion is not fully understood. In particular, the anatomical location, the type of effector cells, and the mechanism underlying anti-CD20 therapy remain uncertain. Here, we found that the liver is a major site for B cell depletion and that recirculation accounts for the decrease in B cell numbers observed in secondary lymphoid organs. Using intravital imaging, we established that, upon anti-CD20 treatment, Kupffer cells (KCs) mediate the abrupt arrest and subsequent engulfment of B cells circulating in the liver sinusoids. KCs were also effective in depleting malignant B cells in a model of spontaneous lymphoma. Our results identify Ab-dependent cellular phagocytosis by KCs as a primary mechanism of anti-CD20 therapy and provide an experimental framework for optimizing the efficacy of therapeutic Abs.


Cite/Figure
PI3K-cite.jpgPI3K-cite.jpgJCI2013-123-12-Fig4A.jpg

Links

https://www.jci.org/articles/view/70972(如需全文,请联系我们)